DKMA Update October 2017

10 October 2017

In this issue of DKMA Update, you can read about the decision to change the dispensing status of a number of opioids, about the new guidelines on medicinal cannabis for doctors, and about the executive order on the import of cannabis products.

This newsletter features the following articles:

  • T cells – new perspectives in cancer treatment
  • More opioids subject to stricter monitoring (dispensing status A§4)
  • Medicinal cannabis – new products, new rules and new guidelines
  • New 9-valent HPV vaccine in the childhood immunisation programme
  • The DKMA is expanding and recruiting new employees
  • New report on biological medicines and biosimilars
  • Global operation against illegal medicines
  • Most recent Direct Healthcare Professional Communications (DHPCs)

Link

DKMA Update, October 2017 (PDF)

Did you get answers to your questions?

Please tell us how we can improve our website?